Homepage | CIDRAP
University of Minnesota http://twin-cities.umn.edu/ 612-625-5000
About CIDRAP | CIDRAP
The Center for Infectious Disease Research and Policy (CIDRAP; "SID-wrap") is a global leader in addressing public health preparedness and emerging infectious disease response. Founded in 2001, CIDRAP is part of the Research and Innovation Office at the University of Minnesota. CIDRAP works to ...
Infectious Disease Topics A-Z - CIDRAP
A comprehensive list of infectious diseases that CIDRAP covers. Our site is an authoritative, reliable, and timely source of science-based information about global, emerging infectious diseases.
Study: 6% of US adults have long COVID, and many have reduced …
6 days ago · Two new studies paint a comprehensive picture of current long COVID cases in the United States, and both suggest the condition limits daily activities for a significant proportion of those affected. In Morbidity and Mortality Weekly Report researchers used data collected from the 2023 Behavioral ...
Long-COVID study shows high rates of cognitive change
3 days ago · Two new studies add to the growing body of literature on the lasting effects of long COVID. In the first, a study of 114 patients with long COVID in Israel, researchers found high rates of depressive disorders (46%), generalized anxiety disorders (21%), sleep disturbances (76%), and reported cognitive changes (95%) among those diagnosed with the condition.
Report describes rare US vancomycin-resistant Staph case
Dec 18, 2024 · James Archer / CDC. A letter published today in Emerging Infectious Diseases describes a case of vancomycin-resistant Staphylococcus aureus (VRSA) identified in North Carolina in 2021. It's just the 16th confirmed case of VRSA identified in the United States since 2002. The case-patient was a 55-year-old man with a history of diabetes, hypertension, arthritis, pulmonary disease, peripheral ...
Study supports ceftolozane-tazobactam over ceftazidime ... - CIDRAP
Dec 17, 2024 · Jennifer Oosthuizen / CDC. A multicenter comparative effectiveness study found that treatment with ceftolozane-tazobactam resulted in higher rates of clinical success than ceftazidime-avibactam for invasive infections caused by multidrug-resistant (MDR) Pseudomonas aeruginosa, researchers reported yesterday in The Lancet Infectious Diseases.. The study, conducted at 28 US hospitals from 2016 ...
CIDRAP in the News
Oct 27, 2024 Advancing influenza vaccines: A review of next-generation candidates and their potential for global health impact paper published in Vaccine is co-authored by Julie Ostrowsky, MSc, et al.. Oct 11, 2024 CIDRAP announces that it has received funding from the Coalition for Epidemic Preparedness Innovations (CEPI) to advance its open-access Coronavirus Vaccines Research and ...
Our Projects - CIDRAP
The Centers of Excellence for Influenza Research and Surveillance (CEIRS) Network Pandemic Research Response Planning project is a cross-center collaborative initiative aimed at enhancing the CEIRS network’s ability to mobilize its scientific expertise and capabilities during an influenza pandemic or pre-pandemic situation and provide research-based knowledge to inform the U.S. Department of ...
Episode 172: A Tunnel of Uncertainty | CIDRAP
Dec 5, 2024 · In "A Tunnel of Uncertainty," Dr. Osterholm and Chris Dall discuss several of Trump's recent HHS nominations, the latest respiratory virus data, and two recent studies on long COVID. Dr. Osterholm also provides an update on the unfolding H5N1 situation and shares another "This Week in Public Health History" segment. The effect of pre-COVID and post-COVID vaccination on long COVID: a systematic ...